Citeline Elevate: Clinical

Accelerated Impact: Disrupting the Status Quo in Clinical Trial Planning & Strategy

Date:
Wednesday May 8th, 2024
Time:
11am to 4:30pm
Location:
Westin Boston Seaport District Hotel (Burroughs Room) | Boston, MA
Register now

Agenda

11:00 - 11:20 
Registration & Networking Drinks
11:20 - 11:30 

Opening remarks

David Laky, General Manager, Clinical & Regulatory, Citeline

11:30 - 12:00

Session 1 - Customer keynote: "Clinical Trial Landscape: Trends and Insights From Across The Industry"

Kenneth Getz, Executive Director, Research Professor (PHCM) Tufts Center for the Study of Drug Development

Suzanne Caruso, SVP New Product Strategy, Norstella 

12:00 - 12:30 

Session 2 - Citeline Keynote: “Utilizing Real-World Data to Optimize Clinical Trial Strategy and Patient Selection”

Duncan Emerton, VP Consulting & Analytics, Citeline 

12:30 - 13:30 
Lunch
13:30 - 14:00   

Session 3 – Fireside chat: "Promise and Peril of AI in Clinical Trial“

Claire Riches, VP Clinical Solutions, Citeline 

Baba Shetty, CTO,
Syneos Health

14:00 - 14:30  

Session 4 – Citeline New Clinical Portfolio Overview: How Citeline supports and accelerates drug development. 

Chris Crucitti, Chief Revenue Officer, Citeline  

Suzanne Caruso, SVP New Product Strategy, Norstella 

14:30 - 15:25

Session 5  – Customer panel: “Towards Unconventional Excellence: A Panel on Disruptive Clinical Trial Strategies with Key Stakeholders”

Moderator

Sarah Karlin-Smith, Senior Writer, Pink Sheet  

Patrick Hughes, Co-founder & Chief Commercial Officer,

Cluepoints   

Georgia Dangel, Senior MSL, Genentech

Matt Winton, Chief Operating Officer, Inozyme Pharma 

Bob Zambon, Vice President, Technology Strategy & Strategic Partnerships, Syneos Health

15:25 - 15:30
Closing remarks
15:30 - 16:30
Closing Networking Drinks
16:30 
End

Register now and we'll save you a seat.


Please check this box to receive communications from Citeline about products, services and content you may find of interest.